Clinical Trials on Hodgkin Disease
Total 377707 results
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Non-hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Multinational Center for Quality of Life Research...UnknownRelapsed or Refractory Hodgkin's LymphomaRussian Federation
-
Peking UniversityPeking University Cancer Hospital & InstituteRecruitingB Cell Non-Hodgkin's LymphomaChina
-
Peking University People's HospitalNot yet recruitingT-cell Non-Hodgkin's Lymphoma
-
Peking UniversityUnknownB-cell Non-Hodgkin's Lymphoma
-
Ortho Biotech Products, L.P.CompletedLeukemia | Anemia | Hodgkin Disease | Lymphoma, Non-hodgkin
-
Affimed GmbHTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Czechia, Germany, Poland
-
NCIC Clinical Trials GroupEastern Cooperative Oncology GroupCompletedHodgkin LymphomaCanada, United Kingdom, Italy
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedRelapsed/Refractory Classical Hodgkin's LymphomaChina
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingB-cell Non-Hodgkin's LymphomaChina
-
Nanjing IASO Biotherapeutics Co.,LtdNot yet recruitingB-cell Non-Hodgkin's Lymphoma
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Worldwide Clinical TrialsSuspendedB-cell Non-Hodgkin's LymphomaUnited States
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
SandozNovartis PharmaceuticalsCompletedIndolent B-cell Non-Hodgkin's LymphomaJapan
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingHodgkin's Lymphoma | Non-Hodgkin LymphomaUnited States
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Gilead SciencesThe Leukemia and Lymphoma SocietyActive, not recruitingNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
Zhao WeiliShanghai Mingju Biotechnology Co., Ltd.Unknown
-
SanofiCompletedLymphoma | Non-HodgkinUnited States
-
S*BIOCompletedLymphoma, Malignant | Hodgkin's Lymphoma | B Cell LymphomaUnited States
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Non-Hodgkins LymphomaCanada
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGRecruitingRelapsed or Refractory Hodgkin's LymphomaItaly
-
TakedaCompletedUntreated CD30-Positive Hodgkin's LymphomaJapan
-
Stanford UniversityNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletedLymphoma | Hodgkin's Lymphoma | Hodgkin DiseaseUnited States
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
Juventas Cell Therapy Ltd.Not yet recruiting
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Sun Yat-sen UniversityRecruitingNon-hodgkin LymphomaChina
-
Swiss Group for Clinical Cancer ResearchTerminatedNon-Hodgkin LymphomaSwitzerland
-
Gilead SciencesTerminatedNon-Hodgkin LymphomaUnited States, France
-
Turku University HospitalCompletedLymphoma | Lymphoma, Non-Hodgkin | Hodgkin DiseaseFinland
-
Lee's Pharmaceutical LimitedUnknownAdvanced Hodgkin's Lymphoma
-
Sheba Medical CenterCompleted
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
CARsgen Therapeutics Co., Ltd.RenJi Hospital; First Affiliated Hospital of Zhejiang UniversityCompletedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-cell Non-Hodgkin LymphomaChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedLymphoproliferative Disorders | Hodgkin Lymphoma | EBV Related Non-Hodgkin's Lymphoma | NonHodgkin Lymphoma | EBV-Related PTLD | EBV Related Lymphoma | EBV Related Hodgkin's LymphomaUnited States
-
Washington University School of MedicineTerminatedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
PeproMene Bio, Inc.City of Hope Medical CenterRecruitingRelapsed or Refractory B-cell Non-Hodgkin's LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityWest China Hospital; Affiliated Hospital of Jiangnan University; The Affiliated... and other collaboratorsRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
University of MiamiTerminatedEpstein Barr Virus Associated Non Hodgkin's Lymphoma | Epstein Barr Virus Associated Hodgkin's Lymphoma | Post-Transplant Lymphoproliferative DiseaseUnited States
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaSpain
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
University of Wisconsin, MadisonGenentech, Inc.TerminatedMantle Cell Lymphoma | Non Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
Molecular Templates, Inc.Terminated
-
Peking UniversityShanghai Mingju Biotechnology Co., Ltd.Unknown
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States